Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9)

Detalles Bibliográficos
Autor principal: Hwang, You-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943277/
https://www.ncbi.nlm.nih.gov/pubmed/31902151
http://dx.doi.org/10.4093/dmj.2019.0213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943277/
https://www.ncbi.nlm.nih.gov/pubmed/31902151
http://dx.doi.org/10.4093/dmj.2019.0213

Ejemplares similares